Infinity Laboratories expands testing capabilities with the launch of Mycoplasma Testing
CASTLE ROCK, CO – April 21, 2020 – Today Infinity Laboratories (infinitylaboratories.com) proudly announced the launch of Mycoplasma testing. Infinity Laboratories is a powerful network of state-of the – art testing facilities that are FDA Registered, ISO 17025 Accredited and DEA licensed. With an enhanced focus in the areas of chemical and microbiological sciences, we support pharmaceutical and medical device manufacturers. Our goal is to go Beyond Testing and become a partner in the success of our customers.
Dan Henderson, CEO/President of Infinity Laboratories stated; “I am very excited to announce our newest testing platform, Mycoplasma Analysis. This launch represents a significant capital investment for Infinity Laboratories and is in direct response to an overwhelming demand within the biological, therapeutics,
and greater pharmaceutical industries. Now more than ever, we value our customer relationships and appreciate the role that we play in the healthcare supply chain”
Mycoplasma, the smallest free-living organisms are frequent contaminants of mammalian cell cultures. It is important for the safety and purity of vaccines and other biological cell-derived products to assure that the cell substrates and unprocessed bulk material used to manufacture these products are free of adventitious agents, including mycoplasma. Generally, mycoplasma contamination represents a serious problem for biomedical research laboratories involved in the development and manufacture of cellderived biological and pharmaceuticals.
According to Kim Lim, VP of Research, Development and Innovation, “Our biotech customers requested that we offer Mycoplasma testing. We researched several platforms with the goal of bringing the most cost-efficient rapid test available to our customers. Real-time PCR is that platform. The PCR technology decreases wait time for results from 2 weeks to down to 7 days, fulfilling the needs of our customers and giving them the edge to bring products to market faster. “
For more information contact:
About Infinity Laboratories
Infinity Laboratories was founded in 1991 on the bedrock principles of excellence, integrity, and quality. Today, the Company is a national chemical and microbiological testing laboratory servicing the pharmaceutical, biotechnology and medical device industries.
For more information about Infinity Laboratories, please visit infinitylaboratories.com
Infinity Laboratories continues to grow scope and reach of services with the acquisition of MicroMed Laboratories
CASTLE ROCK, CO - June 24, 2020 - Infinity Laboratories (infinitylaboratories.com) is proud to announce the acquisition of MicroMed Laboratories of Petaluma, CA. Founded in 1999, MicroMed Laboratories is a publicly held Environmental Monitoring and Testing Services...
Expanded testing capabilities with developed method for Hydroxychloroquine (HCQ). Effective April 16, 2020 - Infinity Laboratories has added a validated method for Hydroxychloroquine and is now receiving final product samples for potency testing. Hydroxychloroquine...
Infinity Laboratories expands testing capabilities with developed method for Hydroxychloroquine (HCQ)
CASTLE ROCK, CO - April 16, 2020 - Today Infinity Laboratories (infinitylaboratories.com) added a validated method for Hydroxychloroquine to its expanding catalog of capabilities and is now receiving final product samples for potency testing. Hydroxychloroquine (HCQ)...